Valuation: Ambu

Market Cap 16.08B 2.45B 2.15B 1.98B 1.86B 3.48B 231B 3.55B 23.84B 9.22B 114B 9.21B 9.01B 397B P/E 2026 *
26.4x
P/E 2027 * 19.7x
Enterprise Value 15.56B 2.37B 2.08B 1.92B 1.8B 3.37B 224B 3.44B 23.06B 8.92B 111B 8.91B 8.72B 384B EV / Sales 2026 *
2.41x
EV / Sales 2027 * 2.13x
Free-Float
50.22%
Yield 2026 *
0.74%
Yield 2027 * 0.95%
Manager TitleAgeSince
Chief Executive Officer 53 20/05/2022
Director of Finance/CFO 42 01/01/2024
Chief Operating Officer 53 10/06/2024
Director TitleAgeSince
Chairman 58 09/12/2020
Director/Board Member 58 14/12/2021
Director/Board Member 63 14/12/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.45B
+0.94%+6.46%-29.59%-13.26% 164B
+1.48%+2.07%-6.03%-6.92% 104B
-0.29%+5.26%-3.52%+52.39% 55.67B
-2.09%-6.13%+51.65%+53.01% 52.92B
+3.00%+8.29%-8.27%-39.21% 42.96B
+2.91%+8.15% - - 32.87B
+2.17%-3.22%-17.52%-43.72% 27.07B
+1.24%+6.98%+60.21%-3.90% 24.79B
+2.41%+6.45%-9.58%+1.73% 21.02B
Average +0.75%+3.42%+4.67%+0.02% 58.32B
Weighted average by Cap. +0.51%+3.85%-5.04%-0.20%

Financials

2026 *2027 *
Net sales 6.45B 985M 863M 796M 745M 1.4B 92.89B 1.43B 9.57B 3.7B 45.91B 3.7B 3.62B 159B 7.18B 1.09B 960M 885M 829M 1.55B 103B 1.59B 10.64B 4.12B 51.05B 4.11B 4.02B 177B
Net income 612M 93.31M 81.82M 75.42M 70.61M 132M 8.8B 135M 906M 351M 4.35B 350M 343M 15.09B 809M 123M 108M 99.79M 93.42M 175M 11.65B 179M 1.2B 464M 5.76B 464M 454M 19.96B
Net Debt -522M -79.67M -69.86M -64.39M -60.28M -113M -7.52B -115M -774M -299M -3.71B -299M -293M -12.88B -809M -123M -108M -99.76M -93.39M -175M -11.64B -179M -1.2B -464M -5.75B -463M -453M -19.95B
Logo Ambu
Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - emergency care and resuscitation devices (50.8%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers; - single-use endoscopes (30.2%); - monitoring and diagnostic devices (19%): including electrodes used in the fields of cardiology, neurophysiology and first aid. At the end of September 2025, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico. Net sales are distributed geographically as follows: Denmark (1%), Europe (38.9%), the United States (49.3%), North America (1.2%) and other (9.6%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
BBB